Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2009-01-20
2011-11-15
Peng, Bo (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S005000, C530S350000
Reexamination Certificate
active
08058012
ABSTRACT:
Five-Helix protein, which comprises the three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, such as amino acid residue linkers, is disclosed. Six-Helix protein, which includes the three N-helices and the three C-helices of the trimer-of-hairpin structure of HIV gp41, separated by linkers, is also disclosed.
REFERENCES:
patent: 5444044 (1995-08-01), Jiang et al.
patent: 5464933 (1995-11-01), Bolognesi et al.
patent: 5656480 (1997-08-01), Wild et al.
patent: 5780221 (1998-07-01), Schumacher et al.
patent: 5840843 (1998-11-01), Jiang et al.
patent: 6090911 (2000-07-01), Petka et al.
patent: 6150088 (2000-11-01), Chan et al.
patent: 6303317 (2001-10-01), Alber et al.
patent: 6372890 (2002-04-01), Koshida
patent: 6506554 (2003-01-01), Chan et al.
patent: 6747126 (2004-06-01), Eckert et al.
patent: 6818740 (2004-11-01), Eckert et al.
patent: 6841657 (2005-01-01), Eckert et al.
patent: 7053179 (2006-05-01), Root et al.
patent: 7226598 (2007-06-01), Eckert et al.
patent: 7402396 (2008-07-01), Chan et al.
patent: 7504224 (2009-03-01), Root et al.
patent: 7811578 (2010-10-01), Eckert et al.
patent: 2003/0082525 (2003-05-01), Root et al.
patent: 2003/0099935 (2003-05-01), Chan et al.
patent: 2004/0213801 (2004-10-01), Wild et al.
patent: 2005/0221294 (2005-10-01), Eckert et al.
patent: 2008/0269462 (2008-10-01), Eckert et al.
patent: WO 94/02505 (1994-02-01), None
patent: WO 96/40191 (1996-12-01), None
patent: WO 98/32848 (1998-07-01), None
patent: WO 00/06599 (2000-02-01), None
patent: WO 00/40616 (2000-07-01), None
patent: WO 01/03723 (2001-01-01), None
patent: WO 01/44286 (2001-06-01), None
patent: WO 02/24735 (2002-03-01), None
patent: WO 02/24735 (2002-03-01), None
Desrosiers, RC. “Prospects or an A DS vaccine” NATLRE Medicine;10(3):221-223; 2004.
Hedestam GB et al. “The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus” Nature Reviews. Microbiology; London, Feb. 2008; vol. 6, Iss.2.
Bahbouhi, B., et al., “Effects of L-and D-REKR Amino Acid-Containing Peptides on HIV and SIV Envelope Glycoprotein Precursor Maturation and HIV and SIV Replication,”Biochem., J. 366 (Pt. 3):863-872 (2002).
Baum, Rudy, “Virus-cell Fusion Targeted for Drug Development,”C&EN(1996).
Benkirane, M., et al., “Antigenicicty and Immunogenicity of Modified Synthetic Peptides Containing D-Amino Acid Residues. Antibodies to a D-Enantiomer Do Recognize the Parent L-Hexapeptide and Reciprocally,”J. Biol. Chem., 268(35):26279-26285 (1993).
Bernstein, Helene B., et al., “Oligomerization of the Hydrophobic Heptad Repeat of gp41,”J. Virology, 69(5):2745-2750 (1995).
Blacklow, Stephen C., et al., “A Trimeric Subdomain of the Simian Immunodeficiency Virus Envelope Glycoprotein,”Biochemistry, 34(46):14955-14962 (1995).
Blake, James and Li, Choh Hao, “Adrenocorticotropin. 47. Synthesis and Biological Activity of Adrenocorticotropic Peptides Modified at the Tryptophan Position,”J. Medicinal Chem., 18(4):423-426 (1975).
Borchardt, Allen, et al., “Small Molecule-Dependent Genetic Selection In Stochastic Nanodroplets As A Means Of Detecting Protein-Ligand Interactions On A Large Scale,”Chem. &Biol., 4(12):961-968 (1997).
Bowie, J.U., et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science, 247:1306-1310 (1990).
Bullough, Per A., et al., “Structure Of Influenza Haemagglutinin At The Ph Of Membrane Fusion,”Nature, 371:37-43 (1994).
Butto, et al., “Dual Infection With Different Strains Of The Same HIV-1 subtype,”AIDS, 11(5):694-696 (1997).
Caffrey, Michael, et al., “Three-Dimensional Solution Structure Of The 44kda Ectodomain Of SIV gp41,”EMBO J., 17(16):4572-4584 (1998).
Cao, Jie, et al., “Effects of Amino Acid Changes in the Extracellular Domain of the Human Immunodeficiency Virus Type 1 gp41 Envelope Glycoprotein,”J. Virology, 67(5):2747-2755 (1993).
Chabala, John C., “Solid-Phase Combinatorial Chemistry And Novel Tagging Methods For Identifying Leads,”Curr.Opin. Biotech., 6:632-639 (1995).
Chakrabartty, Avijit, et al., “Aromatic Side-Chain Contribution to Far-Ultraviolet Circular Dichroism of Helical Peptides and Its Effect on Measurement of Helix Propensities,”Biochemistry, 32:5560-5565 (1993).
Chambers, Philip, et al., “Heptad Repeat Sequences are Located Adjacent to Hydrophobic Regions in Several Types of Virus Fusion Glycoproteins,”Journal of General Virology, 71:3075-3080 (1990).
Chan, David C. and Kim, Peter A., “HIV Entry and Its Inhibition,”Cell, 93:681-684 (1998).
Chan, David C., et al., “Core Structure of gp41 From the HIV Envelope Glycoprotein,”Cell, 89:263-273 (1997).
Chan, David C., et al., “Evidence that a Prominent Cavity in the Coiled Coil of HIV Type I gp41 is an Attractive Drug Target,”Proc. Natl. Acad. Sci. USA, 95:15613-15617 (1998).
Chang, Ding-Kwo, et al., “Proline Affects Oligomerization of a Coiled Coil by Inducing a Kink in a Long Helix,”J. Structural Biology, 128:270-279 (1999).
Chen, Benjamin K., et al. “Distinct Modes of Human Immunodeficiency Virus Type 1 Proviral Latency Revealed by Superinfection of Nonproductively Infected Cell Lines with Recombinant Luciferase-Encoding Viruses,”J. Virology, 68(2):654-660 (1994).
Chen, Charlie L., et al., “One Bead-One Compound Combinatorial Peptide Library: Different Types of Screening,”Methods in Enzymology267:211-219 (1996).
Chen, Chin-Ho, et al., “A Molecular Clasp in the Human Immunodeficiency Virus (HIV) Type 1 TM Protein Determines the Anti-HIV Activity of gp41 Derivatives:Implication for Viral Fusion,”J. Virology, 69(6):3771-3777 (1995).
Chen, Steve, et al., “Mutations in the Leucine Zipper-Like Heptad Repeat Sequence of Human Immunodeficiency Virus Type 1 gp41 Dominantly Interfere with Wild-Type Virus Infectivity,”J. of Virology, 72(6):4795-4774 (1998).
Chen, Yee-Hsiung, et al., “Determination of the Helix and β Form of Proteins in Aqueous Solution by Circular Dichroism,”Biochemistry, 13(16):3350-3359 (1974).
Cole, James L. and Garsky, Victor M., “Thermodynamics of Peptide Inhibitor Binding to HIV-1 gp41,”Biochemistry, 40:5633-5641 (2001).
Corigliano-Murphy, M.A., et al., “Synthesis and Properties of an All-D Model Ribonuclease S-Peptide,”Int. J. Pep. Prot. Res., 25:225-231 (1985).
Delwart, Eric L., et al., “Retroviral Envelope Glycoproteins Contain a “Leucine Zipper”-like Repeat,”AIDS Research and Human Retroviruses, 6(6):703-706 (1990).
Doering Don S. and Matsudaira, Paul, “Cysteine Scanning Mutagenesis at 40 of 76 Positions in Villin Headpiece Maps the F-Actin Binding Site and Structural Features of the Domain,”Biochemistry, 35:12677-12685 (1996).
Dutch, Rebecca Ellis, et al., “Paramyxovirus Fusion Protein: Characterization of the Core Trimer, a Rod-Shaped Complex with Helices in Anti-Parallel Orientation,”Virology, 254:147-159 (1999),
Eckert, D.M., and Kim, P.S., “Design of Potent Inhibitors of HIV-1 Entry from the gp41 N-peptide Region,”PNAS, 98(20):11187-11192 (2001).
Eckert, Debra M. and Kim, Peter S., “Mechanisms of Viral Membrane Fusion and Its Inhibition,”Annual Rev. Biochem.,70: 777-810 (2001).
Eckert, Debra M., et al. “Crystal Structure of GCN4-p1Q1, a Trimeric Coiled Coil with Buried Polar Residues,”J. Mol. Biol., 284:859-865 (1998).
Eckert, Debra M., et a., “Inhibiting HIV-1 Entry: Discovery of D-Peptide Inhibitors that Target the gp41 Coiled-Coil Pocket,”Cell, 99:103-115 (1999).
Eckhart, Leopold, et al., “Immunogenic Presentation of a Conserved gp41 Epitope of Human Immunodeficiency Virus Type I on Recombinant Surface Antigen of Hepatitis B Virus,”J. G
Chan David C.
Kay Michael S.
Kim Peter S.
Root Michael J.
Hamilton, Brooks, Smith & Reynolds, P.C.
Peng Bo
Whitehead Institute For Biomedical Research
LandOfFree
Five-helix protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Five-helix protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Five-helix protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4267425